JP2007507431A - ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法 - Google Patents

ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法 Download PDF

Info

Publication number
JP2007507431A
JP2007507431A JP2006529508A JP2006529508A JP2007507431A JP 2007507431 A JP2007507431 A JP 2007507431A JP 2006529508 A JP2006529508 A JP 2006529508A JP 2006529508 A JP2006529508 A JP 2006529508A JP 2007507431 A JP2007507431 A JP 2007507431A
Authority
JP
Japan
Prior art keywords
kda
around
sprains
molecular weight
muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006529508A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007507431A5 (enExample
Inventor
ロバート・ジョン・ペトレラ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2007507431A publication Critical patent/JP2007507431A/ja
Publication of JP2007507431A5 publication Critical patent/JP2007507431A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2006529508A 2003-10-09 2004-08-27 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法 Withdrawn JP2007507431A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51068403P 2003-10-09 2003-10-09
PCT/CA2004/001579 WO2005032562A1 (en) 2003-10-09 2004-08-27 Methods for treating acute and overuse sprain and strain using hyaluronic acid

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012181003A Division JP2012236855A (ja) 2003-10-09 2012-08-17 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法

Publications (2)

Publication Number Publication Date
JP2007507431A true JP2007507431A (ja) 2007-03-29
JP2007507431A5 JP2007507431A5 (enExample) 2010-12-16

Family

ID=34421822

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2006529508A Withdrawn JP2007507431A (ja) 2003-10-09 2004-08-27 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法
JP2012181003A Pending JP2012236855A (ja) 2003-10-09 2012-08-17 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法
JP2014158462A Pending JP2014205721A (ja) 2003-10-09 2014-08-04 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法
JP2016146163A Pending JP2016185989A (ja) 2003-10-09 2016-07-26 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2012181003A Pending JP2012236855A (ja) 2003-10-09 2012-08-17 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法
JP2014158462A Pending JP2014205721A (ja) 2003-10-09 2014-08-04 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法
JP2016146163A Pending JP2016185989A (ja) 2003-10-09 2016-07-26 ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法

Country Status (14)

Country Link
US (1) US20050080037A1 (enExample)
EP (1) EP1677806B1 (enExample)
JP (4) JP2007507431A (enExample)
CN (1) CN1859918B (enExample)
AT (1) ATE414522T1 (enExample)
AU (1) AU2004277290B2 (enExample)
CA (1) CA2541813C (enExample)
DE (1) DE602004017888D1 (enExample)
DK (1) DK1677806T3 (enExample)
ES (1) ES2317018T3 (enExample)
PL (1) PL1677806T3 (enExample)
PT (1) PT1677806E (enExample)
SI (1) SI1677806T1 (enExample)
WO (2) WO2005032562A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2590159C (en) * 2004-12-30 2011-07-12 Genzyme Corporation Regimens for intra-articular viscosupplementation
EP1968499A1 (en) 2005-12-14 2008-09-17 Anika Therapeutics Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
US20070203095A1 (en) * 2005-12-14 2007-08-30 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
WO2007131546A1 (en) * 2006-05-11 2007-11-22 Sandra Gobbo Hyaluronic acid binary mixtures and therapeutic use thereof
CA2749034C (en) * 2009-01-07 2019-01-15 Robert John Petrella Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
IT1394570B1 (it) * 2009-07-02 2012-07-05 Fidia Farmaceutici Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni.
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
US8575130B2 (en) * 2010-01-04 2013-11-05 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US20110166099A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US20110166098A1 (en) * 2010-01-04 2011-07-07 Wu Tsung-Chung Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
US8722644B2 (en) 2010-01-04 2014-05-13 Holy Stone Healthcare Co., Ltd. Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
US9029347B2 (en) 2010-08-05 2015-05-12 Holy Stone Healthcare Co., Ltd. Method and mixture for treating and preventing inflammatory bowel disease
EP2545925B1 (en) 2011-07-12 2018-02-14 Holy Stone Healthcare Co.,Ltd. Compositions comprising hyaluronic acid for treating and preventing mucosa related diseases
US9907740B2 (en) 2013-01-17 2018-03-06 Jeffrey Hagel Increasing muscular volume in a human using hyaluronic acid
CN106860706A (zh) * 2015-12-10 2017-06-20 仲伟波 双液删刺药液
MX375382B (es) * 2016-04-27 2025-03-06 Anika Therapeutics Inc Métodos y composiciones de uso para el tratamiento de la degeneración de tendón.
WO2025096427A1 (en) * 2023-10-29 2025-05-08 Brown David Donaldson Methods for treating lower back pain with hyaluronic acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US6096728A (en) * 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
EP1560588B1 (en) * 2002-10-16 2011-09-21 ArthroDynamic Technologies, Animal Health Division, Inc. Treatment for traumatic synovitis and damaged articular cartilage

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
JPN6011004171, Ｚａｔｔｏｎｉ，Ｇ．，ｅｔ ａｌ, Ｅｕｒｏｐｅａｎ Ｊｏｕｒｎａｌ ｏｆ Ｒｈｅｕｍａｔｏｌｏｇｙ ａｎｄ Ｉｎｆｌａｍｍａｔｉｏｎ, 1995, Ｖｏｌ．１５， Ｉｓｓｕｅ．１, ｐｐ ６３−６９ *
JPN6011004172, アルツ ディスポ 添付文書, 2001 *
JPN7011000289, 宇都宮 秀昭 他, Ｊｏｕｒｎａｌ ｏｆ Ｊｏｉｎｔ Ｓｕｒｇｅｒｙ, 1995, Ｖｏｌ．１４， Ｎｏ．２, ｐｐ １１２−１１６ *
JPN7011000290, 宗田 大, 診断と新薬, 2001, Ｖｏｌ．３８， Ｎｏ．８, ｐｐ ７１０−７１５ *
JPN7011000291, 福島 稔 他, 薬理と治療, 1993, Ｖｏｌ．２１， Ｎｏ．７, ｐｐ ３２９−３３４ *
JPN7011000292, 山本 龍二, 日本医事新報, 1992, Ｖｏｌ．３５３５, ｐｐ ２４−２７ *
JPN7011000293, 宗田 大, 臨床スポーツ医学, 20030901, Ｖｏｌ．２０， Ｎｏ．９, ｐｐ １０１７−１０２４ *
JPN7011000294, 奥脇 透, 臨床スポーツ医学, 20030901, Ｖｏｌ．２０， Ｎｏ．９, ｐｐ １０２５−１０３１ *

Also Published As

Publication number Publication date
CA2541813C (en) 2011-12-06
CN1859918A (zh) 2006-11-08
EP1677806A4 (en) 2007-04-04
WO2005032562A1 (en) 2005-04-14
EP1677806A1 (en) 2006-07-12
DE602004017888D1 (de) 2009-01-02
DK1677806T3 (da) 2009-02-23
EP1677806B1 (en) 2008-11-19
PT1677806E (pt) 2009-01-29
ATE414522T1 (de) 2008-12-15
CN1859918B (zh) 2010-07-07
AU2004277290A1 (en) 2005-04-14
ES2317018T3 (es) 2009-04-16
PL1677806T3 (pl) 2009-05-29
CA2541813A1 (en) 2005-04-14
JP2014205721A (ja) 2014-10-30
SI1677806T1 (sl) 2009-06-30
WO2005034965A1 (en) 2005-04-21
JP2012236855A (ja) 2012-12-06
JP2016185989A (ja) 2016-10-27
AU2004277290B2 (en) 2010-05-13
US20050080037A1 (en) 2005-04-14

Similar Documents

Publication Publication Date Title
JP2016185989A (ja) ヒアルロン酸を使用する急性及び過用性の捻挫及び筋違いの治療方法
Scale et al. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study
AU2010204445B2 (en) Treatment of soft tissue injury using hyaluronic acid and botulinum toxin
JP2002509890A (ja) 炎症性関節疾患治療用のデキストラン組成物及び治療方法
JP6417488B2 (ja) 疼痛抑制用医薬組成物
WO2012143876A1 (en) A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
JP5636225B2 (ja) 炎症性腸疾患（ｉｂｄ）の治療及び予防に使用するための医薬組成物
TW202114712A (zh) 組成物在製備治療動物或人的受傷肌腱之藥物的用途與套組
RU2299733C1 (ru) Способ лечения дегенеративно-дистрофических заболеваний опорно-двигательного аппарата и посттравматических спаечных процессов
JP2013515024A (ja) 変形性関節症の処置のための組み合わせ
JPH10510294A (ja) 脱蛋白血液透析物の使用方法
HK1166694A (en) Pharmaceutical composition for relieving pain

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070824

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20101025

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110421

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110428

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110630

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110801

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120417

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120817

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20121002